doxazosin has been researched along with Acute Disease in 7 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of modified-release doxazosin 4 mg in the treatment of patients with acute urinary retention (AUR) due to benign prostate gland hyperplasia (BPH)." | 9.13 | Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia. ( López, C; Ortiz, M; Pacheco, JJ; Prieto, L; Romero, J, 2008) |
| "Prospective and randomised study to assess the effectiveness of doxazosin in sustained release formulation in Acute Urinary Retention (AUR) treatment due to benign prostatic hyperplasia (BPH)." | 9.11 | [Doxazosin in the gastrointestinal therapeutic system (GITS) formulation and trial without catheter after acute urinary retention due to BPH. Dose increase action on recovery effect]. ( Arango Toro, O; Bielsa Gali, O; Cañis Sánchez, D; Cortadellas Angel, R; Gelabert Mas, A; Lorente Garín, JA, 2004) |
| "Acute pandysautonomia is a rare disease defined as acute widespread and severe sympathetic and parasympathetic failure and sparing of somatic nerve fibers." | 5.37 | Acute pandysautonomia--restitutio ad integrum by high prednisolone therapy. ( Hödl, S; Mazhar, S; Ransmayr, G; Struhal, W, 2011) |
| "To evaluate the efficacy of modified-release doxazosin 4 mg in the treatment of patients with acute urinary retention (AUR) due to benign prostate gland hyperplasia (BPH)." | 5.13 | Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia. ( López, C; Ortiz, M; Pacheco, JJ; Prieto, L; Romero, J, 2008) |
| "Prospective and randomised study to assess the effectiveness of doxazosin in sustained release formulation in Acute Urinary Retention (AUR) treatment due to benign prostatic hyperplasia (BPH)." | 5.11 | [Doxazosin in the gastrointestinal therapeutic system (GITS) formulation and trial without catheter after acute urinary retention due to BPH. Dose increase action on recovery effect]. ( Arango Toro, O; Bielsa Gali, O; Cañis Sánchez, D; Cortadellas Angel, R; Gelabert Mas, A; Lorente Garín, JA, 2004) |
| "Acute urinary retention is a urological emergency in men and requires urgent catheterisation." | 2.50 | The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. ( Fisher, E; Omar, MI; Subramonian, K, 2014) |
| "Acute pandysautonomia is a rare disease defined as acute widespread and severe sympathetic and parasympathetic failure and sparing of somatic nerve fibers." | 1.37 | Acute pandysautonomia--restitutio ad integrum by high prednisolone therapy. ( Hödl, S; Mazhar, S; Ransmayr, G; Struhal, W, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, E | 1 |
| Subramonian, K | 1 |
| Omar, MI | 1 |
| Prieto, L | 1 |
| Romero, J | 1 |
| López, C | 1 |
| Ortiz, M | 1 |
| Pacheco, JJ | 1 |
| Struhal, W | 1 |
| Hödl, S | 1 |
| Mazhar, S | 1 |
| Ransmayr, G | 1 |
| Hershkovitz, A | 1 |
| Manevitz, D | 1 |
| Beloosesky, Y | 1 |
| Gillon, G | 1 |
| Brill, S | 1 |
| Lorente Garín, JA | 1 |
| Cañis Sánchez, D | 1 |
| Arango Toro, O | 1 |
| Bielsa Gali, O | 1 |
| Cortadellas Angel, R | 1 |
| Gelabert Mas, A | 1 |
| Verhamme, KM | 1 |
| Bosch, RJ | 1 |
| Sturkenboom, MC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial[NCT03314025] | Phase 2 | 158 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for doxazosin and Acute Disease
| Article | Year |
|---|---|
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Device Removal; Doxazosin; Humans; Indoles; Male | 2014 |
3 trials available for doxazosin and Acute Disease
| Article | Year |
|---|---|
Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Delayed-Action Preparations; D | 2008 |
Medical treatment for urinary retention in rehabilitating elderly women: is it necessary?
Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Doxazosin; Female; Humans; Pos | 2003 |
[Doxazosin in the gastrointestinal therapeutic system (GITS) formulation and trial without catheter after acute urinary retention due to BPH. Dose increase action on recovery effect].
Topics: Acute Disease; Aged; Doxazosin; Humans; Male; Prospective Studies; Prostatic Hyperplasia; Urinary Ca | 2004 |
3 other studies available for doxazosin and Acute Disease
| Article | Year |
|---|---|
When you just can't go: my patient, a 63-year old stockbroker, recalled his experience with acute urinary retention.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male | 2009 |
Acute pandysautonomia--restitutio ad integrum by high prednisolone therapy.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Bethanechol | 2011 |
Finasteride in benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Adrenergic alpha-Antagonists; Cohort Studies; Doxazosin | 2004 |